Mesoblast (MESO) Revenue Growth (3y) (2017 - 2023)
Mesoblast (MESO) Revenue Growth (3y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 10.17% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.76% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 979.48% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 42.02% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -91.03% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 7.80% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 59.40% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 76.62% |
| 10 | Mesoblast | 2.01 Bn | 1.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -58.65% |
| Mar 31, 2023 | -2.33% |
| Dec 31, 2022 | 2.72% |
| Sep 30, 2022 | 5.83% |
| Jun 30, 2022 | 4.46% |
| Mar 31, 2022 | 24.50% |
| Dec 31, 2021 | 42.69% |
| Sep 30, 2021 | 30.29% |
| Jun 30, 2021 | 5.50% |
| Mar 31, 2021 | 25.48% |
| Dec 31, 2020 | -27.58% |
| Sep 30, 2020 | 3.59% |
| Jun 30, 2020 | 259.21% |
| Mar 31, 2020 | 86.66% |
| Dec 31, 2019 | 65.67% |
| Sep 30, 2019 | 73.09% |
| Jun 30, 2019 | -58.17% |
| Mar 31, 2019 | -35.32% |
| Dec 31, 2018 | -31.29% |
| Jun 30, 2018 | -23.19% |